Faculty Study Kidney Failure
Published on 30 July 2015
Contrast-induced nephropathy (CIN) is a leading cause of acute renal failure in hospitalized patients. One agent used for the prevention of CIN is N-acetylcysteine (NAC), although studies examining its use for this indication have mixed results. This study was designed to further examine the impact of NAC on the development of CIN. Results showed that certain high-risk patient populations may see benefit in NAC prophylaxis. Based on these results, hospitals may benefit from the development of a protocol to guide the appropriate use of NAC in high-risk patient populations.
The research was first presented in the Journal of Community Hospital Internal Medicine Perspectives. Contributing to the research were College faculty members: Sara Richter, Pharm.D., BCPS, and Andrew Crannage, Pharm.D., BCPS.